WallStreetZenWallStreetZen

NYSEMKT: OGEN
Oragenics Inc Earnings & Revenue

OGEN past revenue growth

How has OGEN's revenue growth performed historically?
Company
-82.77%
Industry
169.3%
Market
17.86%
OGEN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
OGEN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

OGEN earnings and revenue history

Current Revenue
$37.7k
Current Earnings
-$10.1M
Current Profit Margin
-26,946.2%

OGEN Return on Equity

Current Company
-109.7%
Current Industry
15.4%
Current Market
-8.4%
OGEN's Return on Equity (-109.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when OGEN announces earnings.

OGEN Return on Assets

Current Company
-93.8%
Current Industry
2.2%
OGEN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

OGEN Return on Capital Employed

Current Company
-155.79%
Current Industry
17.7%
OGEN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

OGEN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
OGEN$37.65k-$10.08M-$10.15M-82.77%N/A
JAGX$10.72M-$28.25M-$39.71M+19.70%N/A
CMND$0.00-$7.85M-$8.09MN/AN/A
KTRA$0.00-$10.58M-$10.77MN/AN/A
AVTX$2.25M-$28.56M-$33.19M-32.09%N/A

OGEN earnings dates

Next earnings date
May 10, 2024

Oragenics Earnings & Revenue FAQ

What were OGEN's earnings last quarter?

On Invalid Date, Oragenics (NYSEMKT: OGEN) reported Q3 2023 earnings per share (EPS) of -$0.85, up 57.29% year over year. Total Oragenics earnings for the quarter were -$2.01 million. In the same quarter last year, Oragenics's earnings per share (EPS) was -$1.99.

If you're new to stock investing, here's how to buy Oragenics stock.

What was OGEN's earnings growth in the past year?

As of Q1 2024, Oragenics's earnings has grown year over year. Oragenics's earnings in the past year totalled -$10.15 million.

What is OGEN's earnings date?

Oragenics's earnings date is Invalid Date. Add OGEN to your watchlist to be reminded of OGEN's next earnings announcement.

What was OGEN's revenue last quarter?

On Invalid Date, Oragenics (NYSEMKT: OGEN) reported Q3 2023 revenue of $7.47 thousand up 91.32% year over year. In the same quarter last year, Oragenics's revenue was $86.05 thousand.

What was OGEN's revenue growth in the past year?

As of Q1 2024, Oragenics's revenue has grown -82.77% year over year. This is 252.07 percentage points lower than the US Biotechnology industry revenue growth rate of 169.3%. Oragenics's revenue in the past year totalled $37.65 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.